Results 11 to 20 of about 338,209 (343)

Inactivation of Cyclin-Dependent Kinase 5 in Hair Cells Causes Hearing Loss in Mice [PDF]

open access: yesFrontiers in Molecular Neuroscience, 2018
Cyclin-dependent kinase 5 (CDK5) is abundantly expressed in post-mitotic cells including neurons. It is involved in multiple cellular events, such as cytoskeletal dynamics, signaling cascades, gene expression, and cell survival, et al.
Xiaoyan Zhai   +7 more
doaj   +2 more sources

Cyclin-dependent kinase 5 acts as a promising biomarker in clear cell Renal Cell Carcinoma [PDF]

open access: yesBMC Cancer, 2019
Background This research provides the first evidence of CDK5 in ccRCC prognosis and correlation with different p21 expression in overall survival (OS) analysis.
Liangsong Zhu   +4 more
doaj   +2 more sources

Systemic Administration of a Brain Permeable Cdk5 Inhibitor Alters Neurobehavior

open access: yesFrontiers in Pharmacology, 2022
Cyclin-dependent kinase 5 (Cdk5) is a crucial regulator of neuronal signal transduction. Cdk5 activity is implicated in various neuropsychiatric and neurodegenerative conditions such as stress, anxiety, depression, addiction, Alzheimer’s disease, and ...
Alan Umfress   +11 more
doaj   +1 more source

Regulation of Sox6 by cyclin dependent kinase 5 in brain. [PDF]

open access: yesPLoS ONE, 2014
Cyclin dependent kinase 5 (Cdk5) is a proline-directed Ser/Thr kinase involved in various biological functions during normal brain development and neurodegeneration.
Parvathi Rudrabhatla   +3 more
doaj   +1 more source

Cyclin‐dependent kinase‐5 in neurodegeneration [PDF]

open access: yesJournal of Neurochemistry, 2004
AbstractCyclin‐dependent kinase‐5 (CDK5) is predominantly active in the nervous system and it is well established that CDK5 is essential in neuronal development. In addition to its recognized role in development, there is increasing evidence that CDK5 may be involved in the pathogenesis of several neurodegenerative disorders.
Shirley B, Shelton, Gail V W, Johnson
openaire   +3 more sources

Inhibition of Cdk5 Ameliorates Skeletal Bone Loss in Glucocorticoid-Treated Mice

open access: yesBiomedicines, 2022
Glucocorticoids (GCs) are widely used to treat inflammatory diseases. However, their long-term use leads to glucocorticoid-induced osteoporosis, increasing morbidity and mortality. Both anabolic and anti-resorptive drugs are used to counteract GC-induced
Benjamin Thilo Krüger   +8 more
doaj   +1 more source

Regulation of neuronal cav3.1 channels by cyclin-dependent kinase 5 (Cdk5). [PDF]

open access: yesPLoS ONE, 2015
Low voltage-activated (LVA) T-type Ca2+ channels activate in response to subthreshold membrane depolarizations and therefore represent an important source of Ca2+ influx near the resting membrane potential.
Aida Calderón-Rivera   +4 more
doaj   +1 more source

PPM1A Controls Diabetic Gene Programming through Directly Dephosphorylating PPAR?? at Ser273 [PDF]

open access: yes, 2020
Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a master regulator of adipose tissue biology. In obesity, phosphorylation of PPAR gamma at Ser273 (pSer273) by cyclin-dependent kinase 5 (CDK5)/extracellular signal-regulated kinase (ERK ...
Choi, Jang Hyun   +11 more
core   +1 more source

Investigation of the effect of 5-Aza-2'-deoxycytidine in comparison to and in combination with trichostatin a on p16INK4a, p14ARF, p15INK4b gene expression, cell growth inhibition and apoptosis induction in colon cancer Caco-2 cell line

open access: yesInternational Journal of Preventive Medicine, 2021
Background: The cell cycle is divided into four phases, G1, G2, S, and M phase. The mammalian cell cycle is controlled and governed by the kinase complexes including cyclin and the cyclin-dependent kinase (CDK), cyclin-CDK complexes.
Masumeh Sanaei   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy